Prepidil Articles
Forest Labs' Cervidil Approved In USA
10 April 1995
FDA YEAR-END DRUG APPROVALS ROLL-OUT
4 January 1993
FREEZES AT UPJOHN IN STRATEGY REVIEW
8 June 1992
UPJOHN UPDATES ON R&D PROGRESS
13 April 1992
Showing 1-4 of 4 articles
- 1
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
